Topics

Effects of Oral Melatonin on Neurosensory Recovery Following Facial Osteotomies

2016-09-06 16:08:21 | BioPortfolio

Summary

Orthognathic surgery is commonly performed for the treatment of dentofacial deformities. Yet, one of the most prevalent and long-term complication encountered is neurosensory disturbance thus impairing sensation to parts of the face. In Hong Kong, it has been reported that in patients receiving orthognathic surgery, 5.9% experience long-term neurosensory disturbance post-surgery.

Melatonin is a neurohormone that is produced and secreted by the pineal gland in the brain. Its main physiological role in humans is to regulate sleep. Oral Melatonin supplements is also used in the management of jetlag and other sleep disorders. Recently, animal and human studies have shown Melatonin to improve tolerance to pain and to have a neuroprotective and neuroregenerative effect after nerve injuries.

Hence, it is hypothesized that peri-surgical oral Melatonin supplement can improve neurosensory recovery after orthognathic surgery

Description

Background:

Orthognathic surgery is a commonly accepted treatment modality for the management of dentofacial deformities. Although in many cases, satisfying, if not excellent, aesthetic and functional results can be obtained with orthognathic surgeries, this is not without risks; and one of the most prevalent and long-term complication encountered is neurosensory disturbance either in the inferior alveolar nerve or the infraorbital nerve depending on the jaw receiving the osteotomy. A systematic review by Jędrzejewski et al. in 2015 reported cranial nerve injury/sensitivity alteration to be the most common complication after orthognathic surgery and is seen in 50% of cases, and almost all patients will report altered sensation in the immediate post-operative period. Although this will decrease over time, Henzelka et al. have reported a 3% incidence of paresthesia in the inferior alveolar nerve 1 year post-surgery, and Thygesen et al. reported sensory changes in the infraorbital nerve in 7 to 60% of patients depending on site of measurement 1 year post-surgery.1 In Hong Kong, a 10-year retrospective study of 581 patients by Lee et al. in 2013 reported a 5.9% rate of neurosensory disturbance 1-year post-orthognathic surgery. Of these cases, the majority affected the inferior alveolar nerve, and the combination of ramus osteotomies together with anterior mandibular osteotomies significantly increased the chances of permanent neurosensory disturbance.2

Biosynthesis of Melatonin:

Melatonin (N-acetyl-5-methoxytryptamine) is a neurohormone that is endogenously produced and secreted by the pineal gland in the brain in a circadian rhythm, with a plasma concentration highest at night and lowest during the day. Its normal physiological roles in humans are to regulate diurnal rhythm, sleep, mood, immunity, reproduction, intestinal motility, and metabolism. Oral exogenous melatonin has been used in the management of jetlag and other sleep disorders. Recently, animal and human studies have shown melatonin to improve tolerance to tourniquet pain in patients receiving hand surgery performed under regional anaesthesia, to improve dyspnea in patients with chronic obstructive pulmonary disease, and to have a neuroprotective and neuroregenerative effect after nerve injuries.3 - 9

Pharmacology of Melatonin:

i) Bioavailability: The absorption and bioavailability after oral intake of Melatonin varies greatly. Absorption of Melatonin can range from complete in younger patients and decrease to approximately 50% in the elderly. Bioavailability is usually approximately 15% due to variations in first-pass metabolism.11 Peak value is ususally observed 60 - 150min after oral consumption.12 When applied topically to the skin, it has been found that topical application of 0.01% Melatonin cream will increase serum levels of Melatonin from a mean of 4.9pg/mL pre-application to 5.1pg/mL 1-hour post-application to 8.1pg/mL 8-hours post-application, and to 9.0pg/mL 24-hours post-application.13

ii) Distribution: Melatonin is highly lipid-soluble with a protein binding capacity of approximately 60%. In vitro, Melatonin has been shown to mainly bind to albumin, alpha1-acid glycoprotein and high-density lipoprotein. Due to its high lipid-solubility, Melatonin has the ability to cross most membrane barriers, including the blood-brain barrier and placenta and can be found in saliva, serum, and urine after oral administration.14 Melatonin receptors can be found in many tissues throughout the body.

iii) Biotransformation and Excretion: Melatonin is mainly hydroxylated by cytochrome P450 (CYP1A2) in the liver into 6-hydroxymelatonin with a small amount into the serotonin metabolites cyclic 3-hydroxymelatonin and indolinone tautomer of 2-hydroxymelatonin. These are further conjugated to their sulfate and glucuronide conjuates and excreted in the urine.15

Usages of Melatonin:

Aside from the regulating sleep and diurnal rhythm, exogenous Melatonin has been recently proved in animal studies and randomized controlled trials in humans to be beneficial in many other areas of medicine and surgery, mostly hypothesized to be due to its antioxidative properties that reduce inflammatory mediators.

A randomized controlled trial by Mowafi and Ismail in 2008 have shown that in patients who required hand surgery with the use of tourniquet under regional anaesthesia, pre-medication with 10mg oral Melatonin 90 minutes before surgery can significanly reduce verbal pain score for tourniquet pain when compared to the placebo group. The time to the first dose of post-operative analgesic request was significantly longer in the Melatonin group and the amount of post-operative analgesic consumption in the Melatonin group was also significantly lower. No significant difference in the incidence of adverse effects between the Melatonin and placebo groups was reported in the study.3

Animal studies have shown neuroregenerative and neuroprotective effects of Melatonin. In a controlled study in rats, Atik et al. have shown Melatonin to be beneficial in promoting nerve recovery at high doses. In this study, the tibial and peroneal branches of the sciatic nerve were dissected and subsequently coapted with prolene suture. Post-trauma, 10mg/kg Melatonin was injected intraperitoneally for 21 days. Histologically, rats which received Melatonin exhibited less endoneural collagen with better organizad collagen along the repair line of the nerve. There were also fewer demyelinized axons. By 12 weeks post-trauma, walking track analysis showed significantly better function in the Melatonin group when measured with the sciatic function index (SFI). Electrophysiological findings showed that by 12 weeks post-trauma, the latency was significantly less in the Melatonin group, whilst action potential amplitude and nerve conduction velocity were significantly higher in the Melatonin group compared to the control group. It was concluded in this study that high doses of Melatonin has a significant beneficial effect on nerve recovery as measured functionally, histopathologically, and electrophysiologically.4

In another controlled study in rats, Kaya et al. have shown beneficial effects of Melatonin on cut and crush injured sciatic nerve. In this study Melatonin was administered intraperitoneally at a dose of 50mg/kg/day for 6 weeks post-trauma. In terms of SFI values, Melatonin treatment accelerated the recovery process to reach -50 SFI level by the 3rd week, as compared to the placebo group, which only reached this SFI level by the 6th week. Histologically, rats treated with Melatonin showed better strutural preservation of the myelin sheaths compared to the control group. Biochemically, the beneficial effects of Melatonin was further comfirmed by showing lower lipid peroxidation and higher superoxide dismutase, catalase, and glutathione peroxidase activities in sciatic nerve samples when compared to the control group.5

Similar beneficial effects were reported by Zencirci et al. in their study of Melatonin in peripheral nerve crush injury in rats. In their study, rats were allocated into the control group or into the treatment group, which further divided into a group receiving 5mg/kg intraperitoneal Melatonin for 21 days post-trauma, and another group receiving 20mg/kg for the same length of time. Again, they have shown an increase in SFI values in the injured sciatic nerves treated with Melatonin when compared to the control group. Electrophysiological measurements again showed that Melatonin treatment deceased the latency values and increased the conduction velocities. However, it was not mentioned whether significant differences were observed between the group receiving 5mg/kg Melatonin and 20mg/kg Melatonin.6

Fujimoto et al. were also able to show a potent protective effect of Melatonin on spinal cord injury. In this study, experimental ischemic-induced spinal cord injury was inflicted in rats. Subesequently, the rats were either placed in the controlled group or received 2.5mg/kg Melatonin injected intraperitoneally at 5 minutes, then 1, 2, 3, and 4 hours after injury. It was found that Melatonin reduced the occurrence of neutrophil-induced lipid peroxidation. Melatonin also reduced thiobarbituric acid reactive substance content and myeloperoxidase activity, which were responsible for motor deficits. Histologically, findings from the Melatonin group showed less cavity formation than the control group.7

References:

1. Jedrzejewski M, Smektala T, Sporniak-Tutak K, et al. Preoperative, intraoperative, and postoperative complications in orthognathic surgery: a systematic review. Clinical Oral Investigations, 2015; 19:969-77.

2. Lee CTY, Cheung LK, Khambay B, et al. Comparison of surgical management and complication in patients with dentofacial deformities in Hong Kong and Glasgow: A retrospective study. Data in File, 2013.

3. Mowafi HA, Ismail SA. Melatonin improves tourniquet tolerance and enhances postoperative analgesia in patients receiving intravenous regional anesthesia. Anesthesia and Analgesia, 2008;107:1422-6.

4. Atik B, Erkutlu I, Tercan M, et al. The effects of exogenous melatonin on peripheral nerve regeneration and collagen formation in rats. Journal of Surgical Research, 2011;166:330-6.

5. Kaya Y, Sarikcioglu L, Aslan M, et al. Comparison of the beneficial effect of melatonin on recovery after cut and crush sciatic nerve injury: a combined study using fuctional, electrophysiological, biochemical, and electron microscopic analyses. Childs Nervous System, 2013;29:389-401.

6. Zencirci SG, Bilgin MD, Yaraneri H. Electrophysiological and theoretical analysis of melatonin in peripheral nerve crush injury. Journal of Neuroscience Methods, 2010:191;277-82.

7. Fujimoto T, Nakamura T, Ikeda T, et al. Potent protective effects of melatonin on experimental spinal cord injury. SPINE, 2005;25(7):769-75.

8. Cavalcante AGM, de Bruin PFC, de Bruin VMS, et al. Melatonin reduces lung oxidative stress in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled study. Journal of Pineal Research, 2012;53:238-44.

9. Odaci E, Kaplan S. Melatonin and nerve regeneration. International Review of Neurobiology, 2009.

10. Kleszczynski K, Fischer TW. Melatonin and human skin aging. Dermatoendocrinology, 2012:4(3);245-52.

11. Di WL, Kadva A, Johnston A, et al. Variable bioavailability of oral melatonin. The New England Journal of Medicine, 1997;336:1028-9.

12. Waldhauser F, Waldhauser M, Lieberman HR, et al. Bioavailability of oral melatonin in humans. Neuroendocrinology, 1984;39:307-13.

13. Fischer TW, Greif C, Fluhr JW, et al. Percutaneous penetration of topically applied melatonin in a cream and an alcoholic solution. Skin Pharmacology and Physiology, 2004;17(4):190-5.

14. Vakkuri O, Leppaluoto J, Kauppila A. Oral administration and distribution of melatonin in human serum, saliva, and urine. Life Sciences, 1985;37(5):489-95.

15. Ma X, Idle JR, Krausz KW, et al. Metabolism of melatonin by human cytochromes p450. Drug Metabolism and Disposition, 2005;33(4):489-94.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Conditions

Dentofacial Deformities

Intervention

Oral Melatonin 10mg, Placebo

Location

The University of Hong Kong
Hong Kong
Hong Kong

Status

Recruiting

Source

The University of Hong Kong

Results (where available)

View Results

Links

Published on BioPortfolio: 2016-09-06T16:08:21-0400

Clinical Trials [1736 Associated Clinical Trials listed on BioPortfolio]

Interaction Between Body Posture and Nocturnal Sleeping Disorders in Dysgnathic Patients

The role of head posture has been demonstrated in patient with dentofacial deformities. However, the relationship between body posture and jaw disorders is unclear. Moreover, patients with...

Correlation Between Dental Inclination and Bone Thickness in Patients With Class III Dentofacial Deformities

The correlation between tooth inclination and bone thickness and the comparison between thickness measurements and buccolingual inclination before and after dental decompensation will be e...

The Effect of Melatonin on Postoperative Pain Reduction After Orthognathic Surgery

Orthognathic surgery is a procedure performed to correct dentofacial deformities. It involves osteotomy at the facial skeleton. Considerable pain is expected in the early recovery period. ...

Melatonin in Smoke-induced Vascular Injury

The main purpose of this study was to evaluate the effects of melatonin in the regulation of the vascular injury in smokers through population-based, randomized, double-blind, placebo-cont...

Melatonin Oral Gel for Oral Mucositis in Patients With Head and Neck Cancer Undergoing Chemoradiation

The main purpose of this study is to assess the efficacy of melatonin oral gel compared to placebo in the prevention and treatment of oral mucositis in patients with head and neck cancer u...

PubMed Articles [5176 Associated PubMed Articles listed on BioPortfolio]

Short Face Dentofacial Deformities: Changes in Social Perceptions, Facial Esthetics, and Occlusion After Bimaxillary and Chin Orthognathic Correction.

The purpose of this study was to document changes in social perceptions and facial esthetics, and document occlusion outcomes in a series of short face (SF) dentofacial deformity (DFD) subjects. The i...

Management of unpredictable outcomes of costochondral grafts.

Temporomandibular joint (TMJ) ankylosis is a debilitating mandibular hypomobility disorder that may be associated with serious functional and aesthetic deformities including limited mouth opening, imp...

Efficacy of melatonin as an adjunct in the treatment of acute mania: a double-blind and placebo-controlled trial.

This is a double-blind, placebo-controlled, parallel-grouped clinical trial, which was designed to investigate the potential effects of melatonin add-on treatment with lithium and risperidone on acute...

Efficacy of Melatonin in prevention of radiation induced oral mucositis: A randomized clinical trial.

Evaluating the effectiveness of melatonin in prevention of radiation-induced oral mucositis.

Is There a Benefit to the Use of Melatonin in Preoperative Zygomatic Fractures?

We evaluated the effects of melatonin used in the preoperative period for patients who had undergone surgical treatment of a zygomatic fracture.

Medical and Biotech [MESH] Definitions

A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.

An abnormality of the jaws or teeth affecting the contour of the face. Such abnormality could be acquired or congenital.

A family of G-protein-coupled receptors that are specific for and mediate the effects of MELATONIN. Activation of melatonin receptors has been associated with decreased intracellular CYCLIC AMP and increased hydrolysis of PHOSPHOINOSITIDES.

A melatonin receptor subtype primarily found expressed in the BRAIN and RETINA.

A melatonin receptor subtype that is primarily found in the HYPOTHALAMUS and in the KIDNEY.

More From BioPortfolio on "Effects of Oral Melatonin on Neurosensory Recovery Following Facial Osteotomies"

Quick Search

Relevant Topics

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...

Sleep Disorders
Sleep disorders disrupt sleep during the night, or cause sleepiness during the day, caused by physiological or psychological factors. The common ones include snoring and sleep apnea, insomnia, parasomnias, sleep paralysis, restless legs syndrome, circa...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...


Searches Linking to this Trial